BILIBILI INC-SPONSORED ADR (BILI) Forecast, Price Target & Analyst Ratings
NASDAQ:BILI • US0900401060
27.5 USD
+0.92 (+3.46%)
At close: Mar 4, 2026
26.8 USD
-0.7 (-2.55%)
Pre-Market: 3/5/2026, 8:37:45 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BILIBILI INC-SPONSORED ADR (BILI).
Forecast Snapshot
Consensus Price Target
$30.84
+ 12.14% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ1 / 2026
EPS EstimateCN¥1.33
Revenue Estimate7.461B
ChartMill Buy Consensus
82.78%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$30.84
Upside
+ 12.14%
From current price of $27.50 to mean target of $30.84, Based on 36 analyst forecasts
Low
$19.19
Median
$30.60
High
$42.53
Price Target Revisions
1 Month
0.94%
3 Months
1.75%
Price Target Summary
36 analysts have analysed BILI and the average price target is 30.84 USD. This implies a price increase of 12.14% is expected in the next year compared to the current price of 27.5.
The average price target has been revised upward by 1.75% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.78%
BILI was analyzed by 36 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BILI.
In the previous month the buy percentage consensus was at a similar level.
BILI was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-28 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-18 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-14 | Benchmark | Maintains | Buy -> Buy |
| 2025-11-14 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-23 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-10-14 | Macquarie | Initiate | Outperform |
| 2025-08-22 | Benchmark | Maintains | Buy -> Buy |
| 2025-08-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-28 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-07-17 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-08 | Bernstein | Initiate | Outperform |
| 2025-05-21 | HSBC | Upgrade | Hold -> Buy |
| 2025-02-21 | Benchmark | Maintains | Buy -> Buy |
| 2025-02-21 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-18 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-15 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-10-25 | B of A Securities | Maintains | Buy -> Buy |
| 2024-09-03 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-23 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2024-08-23 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2024-08-22 | Nomura | Upgrade | Neutral -> Buy |
| 2024-06-18 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-05-31 | UBS | Upgrade | Neutral -> Buy |
| 2024-05-24 | Benchmark | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ1 / 2026
EPS EstimateCN¥1.33
Revenue Estimate7.461B
Revenue Q2Q6.54%
EPS Q2Q56.07%
Number of Analysts7
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.12%
EPS (1 Month)
0.00%
EPS (3 Months)
-0.40%
Next Earnings Summary
The next earnings revenue estimate has been revised upward by 0.12% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.899B 12.97% | 22.528B 2.87% | 26.832B 19.10% | 30.776B 14.70% | 33.685B 9.45% | 36.69B 8.92% | 41.645B 13.51% | 43.466B 4.37% | 48.561B 11.72% | 51.127B 5.28% | 53.848B 5.32% | N/A | |
| EBITDA YoY % growth | -4.153B -4.16% | -2.165B 47.88% | 1.157B 153.46% | 3.949B 241.26% | 5.364B 35.83% | 6.093B 13.59% | 5.868B -3.69% | 7.571B 29.02% | 7.721B 1.98% | 8.713B 12.85% | 9.783B 12.28% | 10.739B 9.77% | |
| EBIT YoY % growth | -7.49B -16.50% | -5.064B 32.39% | -1.344B 73.46% | 1.194B 188.84% | 2.351B 96.90% | 3.431B 45.94% | 4.307B 25.53% | 6.33B 46.97% | 8.244B 30.24% | 10.717B 30.00% | 13.932B 30.00% | N/A | |
| Operating Margin | -34.20% | -22.48% | -5.01% | 3.88% | 6.98% | 9.35% | 10.34% | 14.56% | 16.98% | 20.96% | 25.87% | N/A | |
| EPS YoY % growth | -16.97 -35.98% | -8.30 51.09% | -0.07 99.16% | 5.87 8,483.45% | 8.10 38.08% | 10.87 34.18% | 13.31 22.46% | 19.29 44.90% | 23.33 20.91% | 27.56 18.15% | 31.33 13.67% | N/A |
All data in CNY
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.33 56.07% | 1.76 36.30% | 1.99 5.27% | 2.53 30.87% | 1.54 16.02% | 2.69 53.10% | 2.64 32.74% | 4.34 71.84% |
| Revenue Q2Q % growth | 7.461B 6.54% | 8.047B 9.67% | 8.566B 11.46% | 9.283B 13.16% | 8.347B 11.88% | 8.961B 11.36% | 9.453B 10.35% | 10.515B 13.27% |
| EBITDA Q2Q % growth | 502.17M 30.70% | 910.24M 68.02% | 825.08M -1.63% | 1.506B 78.70% | 729.62M 45.29% | 1.308B 43.70% | 1.261B 52.83% | 2.111B 40.17% |
| EBIT Q2Q % growth | 83.624M 457.20% | 421.35M 67.46% | 462.69M 30.72% | 870.48M 81.33% | 263.68M 215.32% | 841.66M 99.75% | 795.42M 71.91% | 1.645B 88.98% |
All data in CNY
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
439.84%
EPS Next 5 Year
208.10%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
10.39%
Revenue Next 5 Year
9.77%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
86.19%
EBIT Next 5 Year
49.77%
BILIBILI INC-SPONSORED ADR / BILI Forecast FAQ
What do analysts expect the price target to be for BILIBILI INC-SPONSORED ADR (BILI)?
36 analysts have analysed BILI and the average price target is 30.84 USD. This implies a price increase of 12.14% is expected in the next year compared to the current price of 27.5.
Can you provide the consensus estimates for BILIBILI INC-SPONSORED ADR next earnings?
The consensus EPS estimate for the next earnings of BILIBILI INC-SPONSORED ADR (BILI) is 1.33 USD and the consensus revenue estimate is 7.46B USD.
How many analysts cover BILIBILI INC-SPONSORED ADR (BILI) stock?
The number of analysts covering BILIBILI INC-SPONSORED ADR (BILI) is 36.